Amelioration of bioequivalence protocol screening eyed

Published: 2002-11-05 06:58:00

Updated: 2002-11-05 06:58:00

The Korea Food and Drug Administration said the screening for bioequivalence protocol will be ameliorated in a manner to simplify various procedures prior to implementation of bioequivalence test

The overall review procedure for bioequivalence test will converge on the protection of subjects i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK